Physician profile
Mohammad I Khan
NPI 1558506949
$13,067.69
in general payments reported to CMS, 2019-2025
15 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $48.51 · 2021: $4,714 · 2022: $6,313 · 2023: $926 · 2024: $263 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,065 · Travel and Lodging: $232 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.87 |
| Travel and Lodging | $231.86 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $10,933.45 | 2021-2022 | |
| Intuitive Surgical, INC. | $1,537.02 | 2019-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $99.29 | 2020-2025 | Surgicel Nu-Knit |
| Takeda Pharmaceuticals U.S.A., INC. | $71.98 | 2021-2025 | Gattex |
| Boston Scientific Corporation | $68.31 | 2023 | |
| Aimmune Therapeutics, INC. | $62.64 | 2025 | Zenpep |
| Shire North American Group INC | $56.97 | 2019 | |
| Davol INC. | $55.63 | 2021-2023 | Arista Ah Flexitip |
| Nestle Healthcare Nutrition INC. | $49.28 | 2023 | |
| Smith+Nephew, INC. | $30.59 | 2021-2024 | Collagenase Santyl |
| Baxter Healthcare | $29.99 | 2023 | Perclot |
| Medtronic, INC. | $24.30 | 2025 | Transorb |
| Kci USA, INC. | $23.04 | 2023 | Prevena, V.A.C. Dermatac |
| Abbvie INC. | $13.12 | 2021 | |
| Seagen INC. | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.